Thyroid Disorders in Primary Care: A Practical Guide for General Physicians

Thyroid disorders are common in Indian clinical practice, presenting with symptoms ranging from fatigue and weight changes to menstrual irregularities, palpitations and unexplained changes in mood. Yet these symptoms are often nonspecific, making accurate interpretation of thyroid function tests essential.

For general physicians, understanding thyroid disorders in primary care in India means knowing when to test, how to interpret thyroid-stimulating hormone (TSH) and free thyroxine (FT4), when to treat subclinical hypothyroidism and when specialist referral is necessary.

This practical guide focuses on everyday decisions, including levothyroxine treatment, pregnancy-related considerations and follow-up monitoring.

How Common Is Thyroid Disease in India?

Thyroid disorders represent an important part of India’s endocrine disease burden. Hypothyroidism, hyperthyroidism, autoimmune thyroid disease and thyroid nodules can all present in primary care.

Hypothyroidism may cause fatigue, constipation, cold intolerance, dry skin, weight gain, menstrual disturbances and a slower heart rate. Hyperthyroidism can present with palpitations, tremors, heat intolerance, anxiety, weight loss and increased bowel frequency.

However, symptoms alone cannot confirm thyroid dysfunction. Fatigue, hair loss and weight changes can also result from anaemia, nutritional deficiencies, sleep problems, medication effects and other medical conditions.

A practical approach is to combine the clinical history and examination with appropriately selected laboratory tests. This reduces unnecessary investigations and helps prevent treatment based on a single borderline result.

Interpreting TSH and Free T4 Confidently

TSH is generally the first-line test for evaluating suspected primary thyroid dysfunction in adults without evidence of pituitary disease. FT4 helps determine whether an abnormal TSH represents overt or subclinical disease.

When Should General Physicians Order Thyroid Tests?

Consider thyroid testing when patients have compatible symptoms, an enlarged thyroid, unexplained menstrual changes, relevant autoimmune disease or a history of thyroid surgery or treatment. Testing may also be appropriate in selected patients with atrial fibrillation, unexplained dyslipidaemia or other clinical findings that raise suspicion.

Pregnancy, plans for conception and a history of thyroid disease require particular attention. Testing decisions should follow the patient’s clinical risk and relevant guidance rather than relying on symptoms alone.

Understanding Common TSH and FT4 Patterns

• High TSH with low FT4: Usually indicates overt primary hypothyroidism.
• High TSH with normal FT4: Suggests subclinical hypothyroidism.
• Low TSH with high FT4 and/or FT3: Suggests thyrotoxicosis and requires assessment of the underlying cause.
• Low TSH with normal FT4 and FT3: May indicate subclinical hyperthyroidism.
• Low or normal TSH with low FT4: Requires consideration of central hypothyroidism, severe illness or other explanations.

Always interpret results using the laboratory’s reference range and the patient’s clinical context. Pregnancy, acute illness, certain medicines and assay interference can affect results.

Biotin-containing supplements can interfere with some thyroid laboratory assays. Ask about supplements when results do not fit the clinical picture. If a borderline result is unexpected and the patient is clinically stable, repeat testing may be appropriate after an interval of at least six weeks, depending on the circumstances.

When Should Physicians Check Thyroid Antibodies?

Thyroid peroxidase antibodies (TPOAb) can support an autoimmune cause, particularly when TSH is elevated. They may help estimate the likelihood of progression from subclinical to overt hypothyroidism.

Antibody testing is not necessary for every patient, and repeating positive antibody levels routinely is generally unhelpful. Order tests when the result could influence clinical decisions.

Subclinical Hypothyroidism: Treat or Watch?

Subclinical hypothyroidism is characterised by an elevated TSH with FT4 within the reference range. It can be associated with autoimmune thyroid disease, but mild elevations may also be temporary.

The decision to prescribe levothyroxine should consider the degree and persistence of TSH elevation, symptoms, age, thyroid antibodies, pregnancy plans and relevant cardiovascular risk factors.

When Should Levothyroxine Be Considered?

For non-pregnant adults, NICE recommends considering levothyroxine when TSH is 10 mIU/L or higher on two measurements taken three months apart. For adults younger than 65 with persistent TSH elevation below 10 mIU/L and symptoms suggestive of hypothyroidism, a time-limited treatment trial may be considered.

These thresholds are useful decision aids rather than substitutes for clinical judgement. Pregnancy and fertility-related situations require separate assessment.

For a patient with mildly elevated TSH and no significant symptoms, repeat testing and observation may be preferable to immediate medication. If symptoms persist despite a normal TSH during treatment, reassess other possible causes rather than increasing the dose automatically.

Thyroid Disorders in Pregnancy

Pregnancy changes thyroid hormone requirements and the interpretation of thyroid function tests. Untreated overt hypothyroidism can adversely affect maternal and fetal health, making timely assessment important.

Women with established hypothyroidism should have their thyroid function reviewed promptly when pregnancy is confirmed. Levothyroxine requirements commonly increase during pregnancy, so early dose review and regular monitoring are necessary.

Pregnancy-specific reference ranges should be used where available. Treatment decisions for subclinical hypothyroidism depend on TSH levels, thyroid antibody status, gestational age and applicable clinical guidance.

Levothyroxine should be taken separately from iron and calcium supplements because these can reduce its absorption. A separation of at least four hours is commonly recommended.

Physicians should coordinate care with the obstetric team and consider endocrinology referral when results are difficult to interpret, disease is poorly controlled, or significant hyperthyroidism is suspected.

Levothyroxine Dosing and Follow-Up

Levothyroxine is the standard first-line treatment for primary hypothyroidism. The appropriate dose depends on the patient’s weight, age, severity of hypothyroidism, cardiac status, pregnancy and other clinical factors.

Starting Treatment Safely

Healthy younger adults with overt hypothyroidism may sometimes receive a weight-based replacement dose. Older adults and patients with coronary artery disease generally require a lower starting dose and gradual adjustment.

The dose should be individualised rather than selected from symptoms alone. Patients should be instructed to take levothyroxine consistently, usually on an empty stomach before breakfast, and to separate it from medicines or supplements that interfere with absorption.

How Often Should Thyroid Levels Be Monitored?

TSH is generally checked around six to eight weeks after starting levothyroxine or changing the dose, allowing time for the response to stabilise. Further adjustments depend on the result, symptoms and clinical circumstances.

Once thyroid function is stable, monitoring can usually become less frequent. Patients may need periodic long-term testing, especially when the underlying cause persists, or medicines and health conditions change.

If TSH remains abnormal, review adherence, timing of doses, interacting medicines and possible absorption problems before repeatedly increasing the dose.

Excessive replacement can suppress TSH and contribute to palpitations, arrhythmias and bone loss. The goal is appropriate biochemical control without overtreatment.

When Should a General Physician Refer?

Referral to an endocrinologist or another appropriate specialist should be considered when:

• Thyroid results suggest central hypothyroidism or another pituitary disorder.
• Hyperthyroidism is suspected, and the cause or treatment plan is uncertain.
• Thyroid function remains abnormal despite appropriate treatment and adherence.
• A patient has a significant thyroid nodule, suspicious neck findings or compressive symptoms.
• Thyroid disease complicates pregnancy or fertility treatment.
• Severe symptoms, major biochemical abnormalities or complex medication-related problems require specialist input.

Urgent assessment is necessary for suspected thyroid storm, myxoedema coma or other severe clinical deterioration. These are medical emergencies, not routine outpatient management problems.

Frequently Asked Questions

When should I start levothyroxine?

Treatment is generally indicated for confirmed overt primary hypothyroidism. Subclinical cases require individual assessment based on TSH elevation, symptoms, persistence, age, pregnancy status and other risk factors.

How do I interpret a borderline TSH?

Check the laboratory reference range, symptoms, medicines, supplements and clinical context. If the patient is stable and the result is unexpected, repeat TSH and FT4 after an appropriate interval rather than treating a single borderline value automatically.

Is subclinical hypothyroidism always treated?

No. Some patients require monitoring rather than immediate medication. Persistent TSH of 10 mIU/L or higher commonly supports considering treatment in non-pregnant adults, while milder elevations require a more individualised decision.

How often should thyroid levels be monitored?

Check TSH approximately six to eight weeks after starting or changing levothyroxine. Once stable, monitoring can be less frequent, with timing adjusted for pregnancy, symptoms, medication changes and other clinical factors.

Which thyroid tests should be ordered first?

TSH is generally the initial test for suspected primary thyroid dysfunction in adults. FT4 is added when TSH is abnormal, while both TSH and FT4 are appropriate initially when central thyroid dysfunction is suspected.

Conclusion

Effective management of thyroid disorders in primary care in India depends on accurate test interpretation, appropriate treatment decisions and consistent follow-up. General physicians should distinguish overt from subclinical disease, avoid treating isolated borderline results without context and recognise situations requiring specialist input.

For doctors seeking to strengthen their endocrine knowledge, the Fellowship in Endocrinology, Certificate in Endocrinology and Fellowship in Family Medicine programmes offer relevant educational pathways. Explore the respective programme pages to learn more about their curriculum and clinical learning opportunities.